3 Things Our CSO Wants You To Know About Patient Modeled Audiences

Prior to DeepIntent, most of my career was dedicated to the buy side. Having worked across many pharma brands at various media agencies, I’m all too familiar with the frustrations that media strategists and buyers face when trying to reach campaign-specific patient audiences. Simply put, 3rd party data usage was severely limiting, and patient modeling options were severely lacking. 

Imagine my excitement when we concepted, and then launched, a patient targeting solution that solved for these challenges (and more). 

To my agency friends and past colleagues – here are the three things you should know about our reinvention, Patient Modeled Audiences:


Patient audience models are not one-size-fits-all. Brand and campaign strategy play an important role in identifying your ideal patient audience. 

For example, let’s say you want to raise awareness of a new drug amongst two types of patients: those who are (1) newly diagnosed, and (2) currently being treated with a competitive drug. Before Patient Modeled Audiences, you’d be limited to “off-the-shelf” models, that would be unsuccessful in differentiating between these patient types. 

With Patient Modeled Audiences, you can create and target two distinct audience segments, based on a variety of data points and factors that are suited to your specific strategy and objectives. In fact, our modeled audiences are completely unique; they’re never recreated or reactivated.


Having been in your shoes, I know what you want to know about your audiences. So we give it to you. Advertisers have full visibility into model inputs, scores, and the audience selection process. 

For example, you can see:

  • The number of unique patients we’re modeling against. Once your strategy is implemented, our team provides the count of unique patients based on the campaign-specific claim codes used to direct the modeling.
  • Audience scores and quality. Once the model is exported, we score all users in our platform to measure clinical relevance and direct segmentation. We share and discuss this information with you, and collectively select an effective threshold based on your KPIs.

For example, if your primary KPI is Audience Quality, we’ll select a high threshold (e.g. users who are 75% or more likely to be diagnosed with your condition). If your primary KPI is unique reach, it may make sense to lower the threshold so you reach more potential patients.


We’re past the days of set-it-and-forget-it. Patient Modeled Audiences gives you the flexibility you need to measure, learn, and implement so your campaign delivers maximum efficacy and efficiency. 

We collaborate with our clients to review in-flight performance and 3rd party measurement results, and optimize models accordingly, in-flight.  

For example, let’s say your campaign is live, and you’re reporting DeepIntent as #1 in Audience Quality, but #3 in unique reach. You have the option to rebalance your delivery by lowering the threshold (e.g. from 75% to 70%) to reach more unique users while sustaining acceptable audience quality.  

For these reasons – and more – Patient Modeled Audiences consistently outperforms competitive solutions (check out a recent case study here). 

So if you’re still facing age-old frustrations, I suggest you give Patient Modeled Audiences a look. I’d be glad (and excited) to discuss it with you, myself. 

Jen Werther is DeepIntent’s Chief Strategy Officer. She is responsible for identifying and executing strategic initiatives that underpin DeepIntent’s ongoing success and financial growth. Jen dedicated 10+ years of her career to strategic media planning, buying, and data strategy for pharmaceutical brands, such as GSK, BMS, and Eli Lilly. She’s held positions at various media agencies, including MindShare, PHD, and Ogilvy CommonHealth.

More Insights

DeepIntent at Digital Pharma East
Blog Post
Artificial Intelligence and a Patient-Centric Approach: Highlights from DPE 2023
As one of the most important events in our industry, Digital Pharma East is crucial for furthering the conversation around trends that will impact healthcare...
Read More
DeepIntent IQVIA
Blog Post
An Open Letter to DeepIntent Clients and Partners on the IQVIA Acquisition
As you may know, DeepIntent entered into a definitive agreement to be acquired by IQVIA during the second half of 2022. I’ve committed to keeping...
Read More
Blog Post
Pharma Marketing 101: 5 Things Every Healthcare Marketer Should Know
Pharma marketing is unique. There are two primary audiences (healthcare providers and patients) and only two countries where you can do direct-to-consumer advertising (the U.S....
Read More